References
Dau PC, Kahaleh MB, Sagebiel RW: Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthritis Rheum 1981, 24:1128–1136.
Akesson A, Wolheim FA, Thysell H,: et al.: Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis. Scand J Rheumatol 1988, 17:313–323.
Silver RM, Warrick JH, Kinsella MB, et al.: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993, 20:838–844.
Steen VD, Lanz JK Jr., Conte C, et al.: Therapy for severe interstital lung disease in systemic sclerosis. Arthritis Rheum 1994, 37:1290–1296.
Earle L, Jimenez SA, Steiner RM, et al.: A Pilot Study of Intermittent Intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease. J Rheumatol 1998, 25:1325–1329.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Varga, J., Ponor, I. Clinical trials for the treatment of systemic sclerosis/scleroderma. Curr Rheumatol Rep 1, 13–14 (1999). https://doi.org/10.1007/s11926-999-0018-0
Issue Date:
DOI: https://doi.org/10.1007/s11926-999-0018-0